PATENT CLAIM ANALYSIS

Application Number: 15926223
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "172100"]

Abstract:
The present invention provides antibodies that bind to prokineticin receptors (PROKRs) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human PROKR1 and/or PROKR2. The present invention includes antibodies that bind cell surface-expressed PROKR1 and/or PROKR2. In certain embodiments, the antibodies of the present invention are capable of blocking prokineticin (PK)-mediated activation of one or more PROKR. The antibodies of the invention are useful for the treatment of various diseases and disorders mediated by prokineticin signaling.

Claim (Index 11):
The method of  claim 10  wherein the antibody is an IgG1 antibody.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.92308
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14678347', '14577362', '15805584', '15382256', '14861320']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7136710459551164
- 35 USC 102 Novelty (BERT): 0.5471283783191351
- Combined Prediction Score: 0.6970167791915183
- Mean Citation Score: 285.436388
- Max Citation Score: 432.5264
- Similarity Product: 247.1280999915123

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test